- Lobbying
- Adam AND Steinmetz
Lobbying Arrangements Results for 'Adam Steinmetz'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to water conservation and habitat creation using federal programs |
Ducks Unlimited, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues of interest to the homecare industry S.4605 Preserving Access to Home Health Act of 2022 |
Connolly Enterprises LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to antibody testing |
Aditxt Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Funding for new Petersburg Medical Center facility |
Northern Compass Group LLC OBO Petersburg Medical Center
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Health analytics on deferred care and toxic exposure screening |
Cogitativo, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to land transfer Implementation of Southeast Alaska Regional Health Consortium Land Transfer Act Community project funding for new hospital construction |
Southeast Alaska Regional Health Consortium
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the pharmaceutical supply chain |
AiPharma Global Holdings Limited
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to Healthcare, interoperability, digital cloud fax technology |
Consensus Cloud Solutions
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Engagement regarding VAs Integrated Critical Staffing Program Award. |
Allegis, Redwood, Maxim Public Affairs, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to pharmaceutical manufacturing and supply |
Medivant Healthcare
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to telehealth Telehealth Extension and Evaluation Act Physician coverage and reimbursement issues |
TapestryHealth
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to in-home kidney care Medicare advantage |
Monogram Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) |
Maridose LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Immigration issues related to welfare of undocumented children |
Compass United
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to Medicare coverage and reimbursement and Medicaid coverage and reimbursement |
University of Colorado Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to telehealth and mental health and addiction recovery. Issues related to Medicaid reimbursement |
WEconnect Health Management
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Pandemic preparedness regarding healthcare textiles PREVENT Pandemics Act |
Textile Rental Services Association
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics' Pandemic All Hazards Preparedness Act |
Romark Global Pharma, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Immigration issues related to welfare of undocumented children |
Compass Connections
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to health insurance coverage for hearing aids |
Envoy Medical Corporation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to genomic testing |
PathemaGX
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Funding opportunities for supply chain infrastructure Veteran administration issues |
National Resilience, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to healthcare policy Issues related to telemedicine Rural extenders Issues related to medical debt Issues related to Medicare reimbursement Section 163(j) interest limitation |
CHSPSC, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to production of PPE |
Aegle Corporation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Durable medical equipment coverage and reimbursement Prior authorization |
Enovis Corporation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Drought funding and water conservation Inflation Reduction Act FARM Bill Irrigation efficiency funding Reclamation Inflation Reduction Act Funding |
N-Drip Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to cannabis and the SAFE Banking Act FARM Bill Issues related to IRC Section 280E General corporate tax issues |
The Scotts Miracle-Gro Company
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related workforce development, HCBS Funding Medicaid Reimbursement Nursing staffing requirements |
National Mentor Holdings, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Use of bioscience markers with regard to organ transplant rejection |
CareDx, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Public Health Emergency Policies and Funding Medicare coverage and reimbursement issues Medicaid coverage issues |
TENET HEALTHCARE CORP
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to diagnostic tests. |
SOLVD Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the FARM bill Alcohol excise taxes HR 4073 and S. 1781 To clarify the treatment of drawback in distilled spirits, and for other purposes Issues related to dietary guidelines Corp... |
Pernod Ricard USA
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Pediatric health care issues Medicaid coverage and reimbursement Maternal health Pediatric cancer research funding Global vaccine access and funding PACT ACT and CHGME Funding Global pediatric hea... |
Texas Children's Hospital
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to ACA, Medicare Advantage, and Medicaid Tricare telehealth issues General mental health policy |
Centene Corporation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the HIV/STD community viral hepatitis funding Appropriations Issues related to COVID-19 relief H.R. 5376 - Build Back Better Act |
NMAC (on behalf of the HIV/STD Partnership)
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues |
LifePoint Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers ... |
Cencora, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Engage in advocacy and appropriations measures in support of amFAR's initiatives supporting HIV/AIDs research PEPFAR Reauthorization |
amfAR, The Foundation for AIDS Research
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the Department of Veterans Affairs Report #18-00474-300 H.R.3848 HOME Act of 2023 |
Brentwood School
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act |
Lilly USA, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details issues related to microbiome, oncology, fertility, and health equity Issues related to formulary tier status NDAA FY24 |
Ferring Pharmaceuticals Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Pharmacist provider status Issues related to drug pricing Implementation of the Inflation Reduction Act of 2022 Issues related to access and distribution of pharmaceutical products |
Walgreen Co.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to international vaccine deployment |
ModernaTX, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutic... |
Novartis
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to controlled substances legislation and policy, including DOJ and other appropriations, IRS regulations, and taxation and banking policies; Cannabis Opportunity Act; H.R. 3617, MORE... |
United States Cannabis Council fra Cannabis Trade Federation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the individual marketplace Health insurance tax and general tax issues Part D Issues related to Medicare Advantage H.R.2166 - Ensuring Parity in MA and PACE for Audio-Only Telehea... |
Anthem, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics... |
Cepheid
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to US infrastructure, flood control, MilCON-VA, and LPTA; H.R.5376 Inflation Reduction Act Implementation IIJA Implementation Appropriations NDAA Issues related to the Ukraine rebuild |
Jacobs Engineering Group Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of Inflation Reduction Act of 2022 HELP Copays Act |
ABBVIE
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to scientific, technical, and medical publications Open access language in all appropriations and authorization bills Privacy Issues American Data Privacy and Pr... |
RELX Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP |